Condition: Diabetic Kidney Disease (DKD) · Sponsor: Chinese PLA General Hospital
This trial is to evaluate the efficacy and safety of umbilical cord-derived mesenchymal stromal cells (Amimestrocel ) in study subjects with progressive diabetic kidney disease (DKD), to investigate whether Amimestrocel can improve renal function or proteinuria of DKD patients.
This description comes directly from the study's public registry record.
xiangmei chen · +86 010 66935462 · liping.8@163.com
Always discuss trial participation with your own doctor first.
| Beijing Hospital | Beijing, Beijing Municipality, China | Recruiting |
| China-Japan Friendship Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Capital Medical University Affiliated Beijing Friendship Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Xuanwu Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Chinese PLA General Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06969807